These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Identifying primary and secondary MLH1 epimutation carriers displaying low-level constitutional MLH1 methylation using droplet digital PCR and genome-wide DNA methylation profiling of colorectal cancers. Joo JE; Mahmood K; Walker R; Georgeson P; Candiloro I; Clendenning M; Como J; Joseland S; Preston S; Graversen L; Wilding M; Field M; Lemon M; Wakeling J; Marfan H; Susman R; Isbister J; Edwards E; Bowman M; Kirk J; Ip E; McKay L; Antill Y; Hopper JL; Boussioutas A; Macrae FA; Dobrovic A; Jenkins MA; Rosty C; Winship IM; Buchanan DD Clin Epigenetics; 2023 Jun; 15(1):95. PubMed ID: 37270516 [TBL] [Abstract][Full Text] [Related]
4. Constitutional MLH1 Methylation Is a Major Contributor to Mismatch Repair-Deficient, MLH1-Methylated Colorectal Cancer in Patients Aged 55 Years and Younger. Hitchins MP; Dámaso E; Alvarez R; Zhou L; Hu Y; Diniz MA; Pineda M; Capella G; Pearlman R; Hampel H J Natl Compr Canc Netw; 2023 Jul; 21(7):743-752.e11. PubMed ID: 37433431 [TBL] [Abstract][Full Text] [Related]
5. MLH1-methylated endometrial cancer under 60 years of age as the "sentinel" cancer in female carriers of high-risk constitutional MLH1 epimutation. Hitchins MP; Alvarez R; Zhou L; Aguirre F; Dámaso E; Pineda M; Capella G; Wong JJ; Yuan X; Ryan SR; Sathe DS; Baxter MD; Cannon T; Biswas R; DeMarco T; Grzelak D; Hampel H; Pearlman R Gynecol Oncol; 2023 Apr; 171():129-140. PubMed ID: 36893489 [TBL] [Abstract][Full Text] [Related]
7. EPM2AIP1 immunohistochemistry is inadequate as a surrogate marker for MLH1 promoter hypermethylation testing in colorectal cancer. Challa B; Frankel WL; Knight D; Pearlman R; Hampel H; Chen W Hum Pathol; 2024 Aug; 150():74-77. PubMed ID: 38945374 [TBL] [Abstract][Full Text] [Related]
8. Utility of p16 immunohistochemistry for the identification of Lynch syndrome. Payá A; Alenda C; Pérez-Carbonell L; Rojas E; Soto JL; Guillén C; Castillejo A; Barberá VM; Carrato A; Castells A; Llor X; Andreu M; Koh J; Enders GH; Benlloch S; Jover R Clin Cancer Res; 2009 May; 15(9):3156-62. PubMed ID: 19383812 [TBL] [Abstract][Full Text] [Related]
9. MLH1 region polymorphisms show a significant association with CpG island shore methylation in a large cohort of healthy individuals. Savio AJ; Lemire M; Mrkonjic M; Gallinger S; Zanke BW; Hudson TJ; Bapat B PLoS One; 2012; 7(12):e51531. PubMed ID: 23240038 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive Constitutional Genetic and Epigenetic Characterization of Lynch-Like Individuals. Dámaso E; González-Acosta M; Vargas-Parra G; Navarro M; Balmaña J; Ramon Y Cajal T; Tuset N; Thompson BA; Marín F; Fernández A; Gómez C; Velasco À; Solanes A; Iglesias S; Urgel G; López C; Del Valle J; Campos O; Santacana M; Matias-Guiu X; Lázaro C; Valle L; Brunet J; Pineda M; Capellá G Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32635641 [TBL] [Abstract][Full Text] [Related]
12. [The two-in-one hit model of the short-cut carcinogenesis of colorectal carcinomas in MLH1-associated Lynch syndrome]. Ahadova A; Stenzinger A; Seppälä T; Hüneburg R; Kloor M; Bläker H Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):188-192. PubMed ID: 37932477 [TBL] [Abstract][Full Text] [Related]
13. Testing region selection and prognostic analysis of Tan X; Fang Y; Fan X; Deng W; Huang J; Cai Y; Zou J; Chen Z; Lin H; Xu L; Wang G; Zhan H; Huang S; Fu X Gastroenterol Rep (Oxf); 2024; 12():goae011. PubMed ID: 38566849 [TBL] [Abstract][Full Text] [Related]
14. Targeting mitochondrial DNA polymerase gamma for selective inhibition of MLH1 deficient colon cancer growth. Somuncu B; Ekmekcioglu A; Antmen FM; Ertuzun T; Deniz E; Keskin N; Park J; Yazici IE; Simsek B; Erman B; Yin W; Erman B; Muftuoglu M PLoS One; 2022; 17(6):e0268391. PubMed ID: 35657956 [TBL] [Abstract][Full Text] [Related]
15. Structure of the human MLH1 N-terminus: implications for predisposition to Lynch syndrome. Wu H; Zeng H; Lam R; Tempel W; Kerr ID; Min J Acta Crystallogr F Struct Biol Commun; 2015 Aug; 71(Pt 8):981-5. PubMed ID: 26249686 [TBL] [Abstract][Full Text] [Related]
16. Constitutional Mosaic Epimutations - a hidden cause of cancer? Lønning PE; Eikesdal HP; Løes IM; Knappskog S Cell Stress; 2019 Mar; 3(4):118-135. PubMed ID: 31225507 [TBL] [Abstract][Full Text] [Related]
17. The Two-Hit Hypothesis Meets Epigenetics. Issa JP Cancer Res; 2022 Apr; 82(7):1167-1169. PubMed ID: 35373289 [TBL] [Abstract][Full Text] [Related]
18. Novel insights into tumorigenesis revealed by molecular analysis of Lynch syndrome cases with multiple colorectal tumors. Olkinuora A; Mäki-Nevala S; Ukwattage S; Ristimäki A; Ahtiainen M; Mecklin JP; Peltomäki P Front Oncol; 2024; 14():1378392. PubMed ID: 38725616 [TBL] [Abstract][Full Text] [Related]
19. Constitutional mismatch repair deficiency syndrome with atypical features caused by a homozygous Akrout F; Achour A; Tops CMJ; Gallon R; Meddeb R; Achoura S; Ben Rekaya M; Hamdeni E; Rammeh S; Chkili R; Mansouri N; Belguith N; Mrad R Front Oncol; 2023; 13():1195814. PubMed ID: 37664053 [TBL] [Abstract][Full Text] [Related]
20. MLH1 Deficiency Induces Cetuximab Resistance in Colon Cancer via Her-2/PI3K/AKT Signaling. Han Y; Peng Y; Fu Y; Cai C; Guo C; Liu S; Li Y; Chen Y; Shen E; Long K; Wang X; Yu J; Shen H; Zeng S Adv Sci (Weinh); 2020 Jul; 7(13):2000112. PubMed ID: 32670759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]